Erica C Kaye1, Melanie Stall2, Cameka Woods3, Srilakshmi Velrajan4, Melanie Gattas3, Monica Lemmon5, Justin N Baker3, Jennifer W Mack6,7. 1. St. Jude Children's Research Hospital, Memphis, Tennessee; erica.kaye@stjude.org. 2. The University of Texas Southwestern Medical Center, Dallas, Texas. 3. St. Jude Children's Research Hospital, Memphis, Tennessee. 4. School of Public Health, The University of Memphis, Memphis, Tennessee. 5. Department of Pediatrics, Duke University, Durham, North Carolina. 6. Dana-Farber Cancer Institute, Boston, Massachusetts; and. 7. Boston Children's Hospital, Boston, Massachusetts.
Abstract
BACKGROUND AND OBJECTIVES: Parents of children with cancer perceive deficits in quality of prognostic communication. How oncologists disclose information about disease progression and incurability and how prognostic communication impacts parental understanding of prognosis are poorly understood. In this study, we aimed to (1) characterize communication strategies used by pediatric oncologists to share prognostic information across a child's advancing illness course and (2) explore relationships between different communication approaches and concordance of oncologist-parent prognostic understanding. METHODS: In this prospective, longitudinal, mixed-methods study, serial disease reevaluation conversations were audio recorded across an advancing illness course for children with cancer and their families. Surveys and interviews also were conducted with oncologists and caregivers at specific time points targeting disease progression. RESULTS: Seventeen children experienced advancing illness on study, resulting in 141 recordings (40 hours). Fewer than 4% of recorded dialogue constituted prognostic communication, with most codes (77%) occurring during discussions about frank disease progression. Most recordings at study entry contained little or no prognosis communication dialogue, and oncologists rated curability lower than parents across all dyads. Parent-oncologist discordance typically was preceded by conversations without incurability statements; ultimately, concordance was achieved in most cases after the oncologist made direct statements about incurability. Content analysis revealed 3 distinct patterns (absent, deferred, and seed planting) describing the provision of prognostic communication across an advancing pediatric cancer course. CONCLUSIONS: When oncologists provided direct statements about incurability, prognostic understanding appeared to improve. Further research is needed to determine optimal timing for prognostic disclosure in alignment with patient and family preferences.
BACKGROUND AND OBJECTIVES: Parents of children with cancer perceive deficits in quality of prognostic communication. How oncologists disclose information about disease progression and incurability and how prognostic communication impacts parental understanding of prognosis are poorly understood. In this study, we aimed to (1) characterize communication strategies used by pediatric oncologists to share prognostic information across a child's advancing illness course and (2) explore relationships between different communication approaches and concordance of oncologist-parent prognostic understanding. METHODS: In this prospective, longitudinal, mixed-methods study, serial disease reevaluation conversations were audio recorded across an advancing illness course for children with cancer and their families. Surveys and interviews also were conducted with oncologists and caregivers at specific time points targeting disease progression. RESULTS: Seventeen children experienced advancing illness on study, resulting in 141 recordings (40 hours). Fewer than 4% of recorded dialogue constituted prognostic communication, with most codes (77%) occurring during discussions about frank disease progression. Most recordings at study entry contained little or no prognosis communication dialogue, and oncologists rated curability lower than parents across all dyads. Parent-oncologist discordance typically was preceded by conversations without incurability statements; ultimately, concordance was achieved in most cases after the oncologist made direct statements about incurability. Content analysis revealed 3 distinct patterns (absent, deferred, and seed planting) describing the provision of prognostic communication across an advancing pediatric cancer course. CONCLUSIONS: When oncologists provided direct statements about incurability, prognostic understanding appeared to improve. Further research is needed to determine optimal timing for prognostic disclosure in alignment with patient and family preferences.
Authors: Jacqueline M Kruser; Lauren J Taylor; Toby C Campbell; Amy Zelenski; Sara K Johnson; Michael J Nabozny; Nicole M Steffens; Jennifer L Tucholka; Kris L Kwekkeboom; Margaret L Schwarze Journal: J Pain Symptom Manage Date: 2017-01-04 Impact factor: 3.612
Authors: Justin N Baker; Deena R Levine; Pamela S Hinds; Meaghann S Weaver; Melody J Cunningham; Liza Johnson; Doralina Anghelescu; Belinda Mandrell; Deborah V Gibson; Barbara Jones; Joanne Wolfe; Chris Feudtner; Sarah Friebert; Brian Carter; Javier R Kane Journal: J Pediatr Date: 2015-05-28 Impact factor: 4.406
Authors: Jennifer W Mack; Joanne Wolfe; E Francis Cook; Holcombe E Grier; Paul D Cleary; Jane C Weeks Journal: J Clin Oncol Date: 2007-12-10 Impact factor: 44.544
Authors: Jennifer W Mack; E Francis Cook; Joanne Wolfe; Holcombe E Grier; Paul D Cleary; Jane C Weeks Journal: J Clin Oncol Date: 2007-04-10 Impact factor: 44.544
Authors: Erica C Kaye; Sarah Rockwell; Cameka Woods; Monica E Lemmon; Karen Andes; Justin N Baker; Jennifer W Mack Journal: JAMA Netw Open Date: 2021-08-02
Authors: Sarah L Rockwell; Cameka L Woods; Monica E Lemmon; Justin N Baker; Jennifer W Mack; Karen L Andes; Erica C Kaye Journal: Front Oncol Date: 2022-06-29 Impact factor: 5.738
Authors: Erica C Kaye; Cameka Woods; Srilakshmi Velrajan; Monica E Lemmon; Justin N Baker; Jennifer W Mack Journal: Pediatr Blood Cancer Date: 2021-08-06 Impact factor: 3.838